Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
Study Suggests Disparities in MM Outcomes Persist on a Global Scale
Khylia Marshall
March 12, 2025
Non-Transplant Salvage Therapy Safe for Pediatric, Adolescent Patients with R/R cHL
Anna Azvolinsky, PhD
March 12, 2025
Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia
Katie Robinson
March 5, 2025
Post-Transplant Mutation Clearance Important Indicator of Prognosis for Myelofibrosis
Leah Lawrence
March 5, 2025
Study Maps Clinical Evolution of Fanconi Anemia Using Large Patient Registry
Anna Azvolinsky, PhD
February 26, 2025
Study Confirms Safety, Efficacy of Mitapivat to Improve Anemia, Decrease Pain Crises in Sickle Cell Disease
Khylia Marshall
February 21, 2025
AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia
Leah Lawrence
February 21, 2025
Long-Term Survivors of Multiple Myeloma Have Persistent Immune Alterations
Leah Lawrence
February 21, 2025
Obecabtagene Autoleucel Effective Treatment for Adults with B-ALL
Lara C. Pullen, PhD
February 21, 2025
CRP Levels May Help Stratify VTE Risk in Patients With Cancer on ICIs
Ruth Jessen Hickman, MD
January 30, 2025
Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis
Katie Robinson
January 30, 2025
MRD Status Important Prognostic Factor for R/R MM Treated With T-Cell Redirecting Therapies
Leah Lawrence
January 30, 2025
IL-1β Inhibitor Canakinumab May Be Effective in Specific Genetic Subsets of Lower-Risk MDS
Leah Lawrence
January 30, 2025
Isatuximab Can Be Given as a Shorter Intravenous Infusion to Patients With Multiple Myeloma, New Trial Shows
Anna Azvolinsky, PhD
January 25, 2025
BKV-Related Hemorrhagic Cystitis Poses Significant Risks After HCT in Children
Ruth Jessen Hickman, MD
January 15, 2025
More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma
Katie Robinson
December 13, 2024
New Risk Classification Stratifies Outcomes in Older Intensively Treated Patients with AML
Lara C. Pullen, PhD
December 13, 2024
Discontinuing Maintenance Therapy for Multiple Myeloma Is Feasible, New Study Shows
Anna Azvolinsky, PhD
December 13, 2024
Significant Proportion of Cancer Trials Exclude Individuals with Duffy Null–Associated Neutrophil Count, Study Finds
Anna Azvolinsky, PhD
November 22, 2024
Lactated Ringer Preferred Over Normal Saline in SCD Vaso-Occlusive Episodes
Ruth Jessen Hickman, MD
November 22, 2024

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
March 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals